AN2 Therapeutics
ANTX
ANTX
18 hedge funds and large institutions have $134M invested in AN2 Therapeutics in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
1 | +$55.3M | |
2 | +$24.4M | |
3 | +$20.6M | |
4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$10.4M |
5 |
DM
Deerfield Management
New York
|
+$8.8M |
Top Sellers
No sellers this quarter